Sigma Healthcare

Sigma Healthcare (SIG) Stock Price, Fundamentals & Analysis

StockASXASX 200Healthcare

Price

2.57 AUD

-0.39%

Last trade: Sep 25, 2026, 04:10 PM GMT+10

Updated: Sep 27, 2026, 07:48 PM GMT+10

Price history

Over the past year SIG traded between 2.5 AUD and 3.16 AUD, closing at 2.57 AUD on Sep 25, 2026.

Key statistics

Market cap29.56B AUD
P/E ratio (TTM)42.8
Forward P/E28.8
EPS (TTM)0.06 AUD
Dividend yield1.56%
Annual dividend0.04 AUD
Ex-dividend dateSep 3, 2026
Payout ratio53%
52-week range2.47 – 3.2
52-week change-14.3%
Beta0.32
Price / book5.92
Revenue (TTM)10.83B AUD
Revenue growth (YoY)31.9%
Gross margin18.1%
Operating margin8.5%
Profit margin6.5%
Return on equity14.7%
Debt / equity40.5
Volume12,264,109
Average volume16,950,173
Next earningsAug 27, 2026
ExchangeASX

Profile

Sector
Healthcare
Industry
Medical Distribution
Headquarters
Preston, Australia

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.

Overview

What SIG does

Sigma Healthcare (SIG) is a stock listed on the ASX that operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia and internationally. The company distributes pharmaceutical, medical, healthcare, and beauty products to a network of franchised retail pharmacies and other third parties, and also provides advertising, marketing, and support services to that network. Its platform includes MPS Connect, an end-to-end medication management solution. Sigma Healthcare operates stores under the Chemist Warehouse, Amcal, Discount Drug Stores, and PriceSave brand names, and also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia. Within the Australian healthcare space, it is a peer to companies such as 4DMedical (4DX), Cochlear (COH), Mesoblast (MSB), Sonic Healthcare (SHL), Fisher & Paykel Healthcare (FPH), Regis Healthcare (REG), and Telix Pharmaceuticals (TLX).

Key numbers explained

  • 2.57 AUD is the current share price, the amount you would pay for one share of Sigma Healthcare on the ASX.
  • The trailing P/E ratio of 42.8 divides the current share price by the last 12 months of earnings per share (0.06 AUD); a higher number can mean the market expects strong future growth or that the stock is priced at a premium relative to recent earnings.
  • The forward P/E ratio of 28.8 uses expected future earnings instead of past earnings, which can make the valuation look lower if earnings are expected to grow.
  • The dividend yield of 1.56% shows the annual dividend as a percentage of the share price; it is a measure of cash income relative to the price you pay.
  • The ex-dividend date of 3 Sept. 2026 is the cutoff: you must own the stock before this date to receive the next dividend payment.
  • 53% of earnings are paid out as dividends, meaning the company returns a little more than half of its profit to shareholders and reinvests the rest.
  • Beta of 0.32 suggests the stock has historically moved less than the overall market, which can mean lower volatility.
  • The 52-week range of 2.47 – 3.2 shows the lowest and highest prices in the past year; the current price of 2.57 AUD sits near the lower end of that range.
  • The price change over the last 52 weeks of -14.3% indicates the stock has declined from one year ago to today.
  • Revenue growth of 31.9% year over year shows that trailing 12-month revenue of 10.83 mld. AUD has expanded significantly compared with the prior period.
  • Profit margin of 6.5% and operating margin of 8.5% describe how much of each revenue dollar remains as profit after costs and operating expenses, respectively.
  • Return on equity of 14.7% measures how effectively the company generates profit from shareholders' equity.
  • The debt-to-equity ratio of 40.5% compares interest-bearing debt to shareholders' equity, indicating the level of financial leverage.
  • Price to book of 5.92 compares the share price to the company's book value per share; a higher number can reflect intangible value or market optimism.

What to watch

  • Revenue growth and margin trends: because Sigma Healthcare operates in a regulated, cost-sensitive industry, changes in drug pricing, reimbursement rates, and input costs can affect both top-line growth and profitability.
  • Dividend policy: the 53% payout ratio and the 1.56% yield are tied to earnings; if earnings fluctuate, the dividend level and yield may adjust as well.
  • Valuation multiples: the trailing P/E ratio of 42.8 and forward P/E ratio of 28.8 can shift quickly as earnings expectations change, so comparing them with peers such as Cochlear (COH) or Sonic Healthcare (SHL) can provide context.
  • Market and sector risk: as a healthcare stock, Sigma Healthcare can be influenced by regulatory changes, public health trends, and broader market movements, as reflected in its low beta of 0.32.
  • Earnings timing: the next earnings release is scheduled for 27 Aug. 2026, which is a common catalyst for price and valuation updates.

Latest news & filings

No recent headlines.

Frequently asked questions

Does SIG pay a dividend?

Yes. Sigma Healthcare pays a dividend, with a yield of 1.56% and an ex-dividend date of 3 Sept. 2026.

What is the SIG P/E ratio?

The trailing P/E ratio is 42.8, and the forward P/E ratio based on expected earnings is 28.8.

Where can I buy SIG?

Sigma Healthcare trades on the ASX under the symbol SIG, so you can buy it through any broker that provides access to the Australian market.

How big is Sigma Healthcare?

Its market capitalisation is 29.56 mld. AUD, with trailing 12-month revenue of 10.83 mld. AUD.

Is Sigma Healthcare a stable stock?

It has a low beta of 0.32, which historically suggests lower volatility than the broader market, and a debt-to-equity ratio of 40.5%.

How much of earnings does SIG return to shareholders?

53% of earnings are paid out as dividends.

Track SIG in your portfolio

Hold SIG at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.

Start free

Data updated Sep 27, 2026, 07:48 PM GMT+10. Sources: Yahoo Finance, Bucharest Stock Exchange.

For information and education only — not investment advice. Prices may be delayed. The overview is generated with AI from the data shown on this page.